Carry-over effects in GAG therapy efficacy trial solution for bladder pain syndrome/interstitial cystitis (GETSBI study): an interim analysis
Objectives The double blind, multicentre, randomised, placebo-controlled GAG-therapy Efficacy Trial Solution for Bladder pain syndrome/Interstitial cystitis (GETSBI) study aims to evaluate the efficacy of intravesical glycosaminoglycans therapy with hyaluronic acid and chondroitin sulfate in symptom...
Saved in:
| Main Authors: | Thomas J Hoogeboom, Charlotte van Ginkel, John Heesakkers, Frank Martens, Dick Janssen, J M M Groenewoud |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2025-06-01
|
| Series: | BMJ Open |
| Online Access: | https://bmjopen.bmj.com/content/15/6/e092757.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Microbiome profiling in patients with Bladder Pain Syndrome/Interstitial cystitis
by: Puck Oude Elferink, et al.
Published: (2025-06-01) -
Hyaluronic acid: Function and location in the urothelial barrier for bladder pain syndrome/interstitial cystitis, an in vitro study.
by: Charlotte J van Ginkel, et al.
Published: (2025-01-01) -
Re: Hydrodistention of the Bladder for the Treatment of Bladder Pain Syndrome/Interstitial Cystitis (BPS/IC)
by: İlker Şen
Published: (2017-06-01) -
BOTULINUM TOXIN A FOR THE MANAGEMENT OF INTERSTITIAL CYSTITIS/BLADDER PAIN SYNDROME
by: V. L. Medvedev, et al.
Published: (2017-10-01) -
Addressing quality of life in the patient with interstitial cystitis/bladder pain syndrome
by: Vinaya Vasudevan, et al.
Published: (2017-01-01)